HURA Financials | Key Metrics & Investor Analysis
The financial statements for HURA (HURA) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| SPRO Spero Therapeutics, Inc. | $2.80 -1.41% |
| R Ryder System, Inc. | $230.98 +0.40% |
| MCRB Seres Therapeutics, Inc. | $8.50 -4.92% |
| VTGN VistaGen Therapeutics, Inc. | $0.61 -0.54% |
| U Unity Software Inc. | $25.41 -4.22% |
| INO Inovio Pharmaceuticals, Inc. | $1.13 -4.24% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | $2.80 | -1.41% | 162.10 M | 18.67 | 0.15 | 0.00% | Hold | 256 |
| R Ryder System, Inc. | $230.98 | +0.40% | 9.11 B | 19.26 | 11.99 | 0.79% | Buy | 323 |
| MCRB Seres Therapeutics, Inc. | $8.50 | -4.92% | 81.48 M | 13.28 | 0.64 | 0.00% | Hold | 25 |
| VTGN VistaGen Therapeutics, Inc. | $0.61 | -0.54% | 19.84 M | -0.32 | -1.90 | 0.00% | Buy | 368 |
| U Unity Software Inc. | $25.41 | -4.22% | 11.09 B | -26.47 | -0.96 | 0.00% | Hold | 13.02 |
| INO Inovio Pharmaceuticals, Inc. | $1.13 | -4.24% | 60.56 M | -0.62 | -1.81 | 0.00% | Buy | 2.08 |
Frequently Asked Questions
What are HURA's latest financial results?
Review HURA's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has HURA's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is HURA's cash flow situation and liquidity?
Cash flow statements reveal how HURA generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does HURA's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether HURA is outperforming or lagging within its sector.
Are HURA's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether HURA's profits are repeatable and supported by strong fundamentals.